SC
IMPV

Sculptor Capital’s Imperva, Inc. IMPV Stock Holding History

Sculptor Capital’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-228,600
Closed -$8.78M – 442
2016
Q4 		$8.78M Buy
+228,600
New +$9.28M 0.06% 164
2016
Q3 		– Sell
-795,400
Closed -$34.2M – 414
2016
Q2 		$34.2M Buy
+795,400
New +$33.4M 0.2% 104

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Sculptor Capital's IMPV Position: Q4 2017 in Review

Sculptor Capital sold out of Imperva, Inc. (IMPV) in Q4 2017, closing a stake of 86,615 shares — an estimated $3.76M sold.

Sculptor Capital first reported a position in IMPV in Q1 2016 and held it in 4 quarters. The position peaked at $7.49M in Q1 2016. 175 funds tracked by Wall St. Rank hold IMPV as of Q4 2017.

  • Sculptor Capital reported no remaining Imperva, Inc. position as of Q4 2017 after selling out during the quarter.
  • Sculptor Capital sold 86,615 Imperva, Inc. shares in Q4 2017, an estimated $3.76M.
  • Sculptor Capital first reported a position in Imperva, Inc. in Q1 2016 and held it in 4 quarters.
  • Sculptor Capital's Imperva, Inc. position peaked at $7.49M in Q1 2016.
  • 175 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2017.

Based on Sculptor Capital's 13F filing for Q4 2017, filed 13 Feb 2018.